Detection of TP53 dysfunction in chronic lymphocytic leukemia by an in vitro functional assay based on TP53 activation by the non-genotoxic drug Nutlin-3: a proposal for clinical application.
Pozzo F, Dal Bo M, Peragine N, Bomben R, Zucchetto A, Rossi F, Degan M, Rossi D, Chiarenza A, Grossi A, Di Raimondo F, Zaja F, Pozzato G, Secchiero P, Gaidano G, Del Poeta G, Zauli G, Fo À R, Guarini A, Gattei V.
Pozzo F, et al. Among authors: zauli g.
J Hematol Oncol. 2013 Nov 5;6:83. doi: 10.1186/1756-8722-6-83.
J Hematol Oncol. 2013.
PMID: 24283248
Free PMC article.